AssayIndex
SWB cross-section

SWB by compound

SWB records split by compound, with the index-wide comparison for the same compound beside each one. 24 compounds, 204 records. Cells below n=3 print their raw values instead of a median.

24 compounds204 records
CompoundClassReportsSWB median %Index median %Δ (pp)SpecPass %
TirzepatideIncretin3198.7198.55+0.1697.094
SemaglutideIncretin2698.6498.89-0.2597.0100
RetatrutideIncretin2098.2598.37-0.1396.5100
IGF-1 LR3Growth-hormone1997.5898.28-0.7095.0100
5-Amino-1MQNon-peptide1399.3499.45-0.1198.0100
IpamorelinGrowth-hormone1399.6199.47+0.1499.0100
AOD-9604Metabolic1099.3599.29+0.0698.0100
CJC-1295 (no DAC)Growth-hormone899.2099.09+0.1198.0100
P21Neuroactive899.2399.230.0098.0100
CJC-1295 with DACGrowth-hormone7 n=798.3898.95-0.5797.5100
L-Glutathione (reduced)Short7 n=799.0099.33-0.3398.5100
N-Acetyl Semax AmideNeuroactive7 n=799.4099.35+0.0598.5100
MGFGrowth-hormone6 n=698.5699.29-0.7397.5100
PT-141 (Bremelanotide)Melanocortin-receptor6 n=699.2399.38-0.1598.5100
MK-677 (Ibutamoren mesylate)Non-peptide4 n=499.5699.49+0.0798.5100
BPC-157Tissue-repair4 n=499.3899.16+0.2298.0100
ExenatideIncretin4 n=499.4198.98+0.4398.0100
GonadorelinHypothalamic3 n=399.0299.12-0.1098.5100
SelankNeuroactive2 n=2n<399.5999.0100
Enclomiphene citrateNon-peptide2 n=2n<399.4498.5100
CagrilintideIncretin1 n=1n<398.6996.5100
IGF-1 DES (1-3)Growth-hormone1 n=1n<399.1295.0100
MazdutideIncretin1 n=1n<398.1496.5100
Thymosin α1Tissue-repair1 n=1n<399.4097.5100
96.697.297.898.499.099.6100.2TirzepatideTirzepatide: Q1 98.32, median 98.71, Q3 99.00, n=31outlier 96.85outlier 96.97outlier 97.29outlier 97.29n=31SemaglutideSemaglutide: Q1 98.30, median 98.64, Q3 98.93, n=26n=26RetatrutideRetatrutide: Q1 97.92, median 98.25, Q3 98.66, n=20n=20IGF-1 LR3IGF-1 LR3: Q1 97.20, median 97.58, Q3 98.22, n=19n=195-Amino-1MQ5-Amino-1MQ: Q1 99.24, median 99.34, Q3 99.57, n=13n=13IpamorelinIpamorelin: Q1 99.49, median 99.61, Q3 99.73, n=13n=13AOD-9604AOD-9604: Q1 99.16, median 99.35, Q3 99.39, n=10outlier 99.93n=10CJC-1295 (no DAC)CJC-1295 (no DAC): Q1 99.06, median 99.20, Q3 99.26, n=8outlier 99.93n=8P21P21: Q1 99.04, median 99.23, Q3 99.43, n=8n=8CJC-1295 with DACCJC-1295 with DAC: Q1 98.31, median 98.38, Q3 98.47, n=7n=7L-Glutathione (reduce…L-Glutathione (reduce…: Q1 98.91, median 99.00, Q3 99.09, n=7outlier 98.59outlier 99.39n=7N-Acetyl Semax AmideN-Acetyl Semax Amide: Q1 99.30, median 99.40, Q3 99.44, n=7outlier 98.93n=7MGFMGF: Q1 98.47, median 98.56, Q3 98.57, n=6outlier 98.03outlier 99.09n=6PT-141 (Bremelanotide)PT-141 (Bremelanotide): Q1 99.11, median 99.23, Q3 99.54, n=6n=6 Purity (% area)
Figure. Distribution per compound where n ≥ 4. Rows are ordered by coverage, not by result.

Which of these lines SWB actually stocks

Coverage here reflects what has been submitted to the index, not what is on the catalogue. Shanghai Wibson Biotechnology Co., Ltd. lists considerably more than the 24 compounds above. Of those 24, 14 have been seen arriving from a domestic warehouse rather than as a cross-border consignment — that is the whole of what the index can say about which lines are held in regional stock, and it is a record of what was submitted, not a stock position. The catalogue and the current stock position are on the supplier's own site.

Browse the SWB catalogue at shanghaiwibsonbiotechnology.net →